Terra Corley
Vascular Surgery · Oklahoma City, OKNPI 1871184895
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,600 of the $6,596 with a category attached, or 84.9%. 26 manufacturers reported payments, led by Silk Road Medical, Inc. at 33.9% of the total. Reporting peaked in 2022 at $2,311 and has fallen 58.8% since, to $952 in 2025. That places this record below the midpoint for vascular surgery clinicians in OK, where the typical reported total is $6,612.
Across 159 payments — averaging $41.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$2K
- Philips North America LLC$2K
- Johnson & Johnson$466
- Novo Nordisk$257
- Boston Scientific$239
- E.r. Squibb & Sons, L.L.C.$237
- plus $2K from 20 others
What the payments were for
- Travel & lodging$98715%
- Food & beverage$5,60085%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 24 | $2,238 |
| Philips North America LLC | 40 | $1,581 |
| Johnson & Johnson | 36 | $466 |
| Novo Nordisk | 10 | $257 |
| Boston Scientific | 4 | $239 |
| E.r. Squibb & Sons, L.L.C. | 14 | $237 |
| Nevro Corp. | 3 | $197 |
| Abbott | 2 | $189 |
| Medtronic | 2 | $173 |
| Endologix LLC | 2 | $173 |
| Bolton Medical Inc | 2 | $157 |
| Nalu Medical, Inc. | 1 | $143 |
| Mannkind Corporation | 1 | $125 |
| AstraZeneca | 1 | $70 |
| Merck | 4 | $59 |
| Baxter Healthcare | 1 | $58 |
| Chiesi USA, Inc. | 1 | $49 |
| Amarin Pharma, Inc. | 3 | $44 |
| Kerecis Limited | 1 | $25 |
| Cvrx, Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Amgen | 1 | $19 |
| Novartis | 1 | $15 |
| Pfizer | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Surmodics, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$3,618
- ENROUTE Transcarotid Stent$1,886
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,608
- ENDURANT IIS$158
- Torus Stent Graft System$149
- ENDOCROSS Device$149
- Nalu Neurostimulation System$143
- TREO ABDOMINAL STENT-GRAFT SYSTEM$140
- Senza$134
- AFREZZA$125
- Ozempic$117
How this compares
$6,596 in reported general payments places this provider in the 45th percentile of 35 vascular surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $123 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Oklahoma City
- Jim MeltonOklahoma City$131K
- Lenny StubbsOklahoma City$56K
- Ali AminOklahoma City$41K
- Bernardino RochaOklahoma City$34K
- Clifford HowellOklahoma City$17K
- Sherisa WarrenOklahoma City$15K
- Jones ThomasOklahoma City$14K
- Trenton KinnearOklahoma City$10K
- Donald SpadoneOklahoma City$9K
- James NeelOklahoma City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.